Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status

Faber, E. B., Baca, Y., Xiu, J., Walker, P., Manji, G., Gholami, S., Saeed, A., Prakash, A., Botta, G. P., Sohal, D., Lenz, H. J., Shields, A. F., Nabhan, C., El-Deiry, W., Seeber, A., Chiu, V., Hwang, J., & Lou, E. (2024). Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status. ESMO Gastrointestinal Oncology, 4, 100042. https://doi.org/10.1016/j.esmogo.2024.100042
Authors:
Erik B. Faber
Yasmine Baca
Joanne Xiu
Phillip Walker
Gulam A. Manji
Sepideh Gholami
Anwaar Saeed
Ajay Prakash
G.P. Botta
Davendra Sohal
Heinz‐Josef Lenz
Anthony F. Shields
Chadi Nabhan
Wafik S. El‐Deiry
Andreas Seeber
Vi K. Chiu
Justin H. Hwang
Emil Lou
Affiliated Authors:
Gulam A. Manji
Publication Type:
Article
Unique ID:
10.1016/j.esmogo.2024.100042
Publication Date:
Data Source:
OpenAlex

Record Created: